Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Total Liabilities 2022–2025
Indivior Pharmaceuticals, Inc. annual total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Indivior Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 1.30B, a 21.31% decrease year-over-year.
- Indivior Pharmaceuticals, Inc. total liabilities for 2025 were 1.30B, a 21.31% decrease from 2024.
- Indivior Pharmaceuticals, Inc. total liabilities for 2024 were 1.65B, a 14.93% decrease from 2023.
- Indivior Pharmaceuticals, Inc. total liabilities for 2023 were 1.94B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Indivior Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1,300 |
| 2024 | $1,652 |
| 2023 | $1,942 |
Indivior Pharmaceuticals, Inc. Total Liabilities — FAQ
Indivior Pharmaceuticals, Inc. (INDV) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INDV's total liabilities history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.